Susanne Kindermann, PhD

Regulatory Group Director at F. Hoffmann-La Roche AG

Speaker

Susanne Kindermann is a Regulatory Group Director in CMC Regulatory Affairs at Roche, Switzerland. She has 18 years of diverse industry experience spanning start-up environments, CMOs, and large pharmaceutical companies.
Holding a PhD in Chemistry, Susanne currently leads the global cmc regulatory strategy for Roche's New Modalities portfolio, including oligonucleotides, peptides, and synthetic molecules. Her work is dedicated to translating innovative drug development into successful global Health Authority approvals. She is a member of the European Pharma Oligonucleotide Consortium (EPOC).